<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Cross-continuum topics in stroke management. In: Canadian best practice recommendations for stroke care.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Cross-continuum topics in stroke management. In: Lindsay MP, Gubitz G, Bayley M, Hill MD, Davies-Schinkel C, Singh S, Phillips S, Canadian Stroke Strategy Best Practices and Standards Writing Group. Canadian best practice recommendations for stroke care. Ottawa (ON): Canadian Stroke Network; 2010 Dec 8. p. 151-70.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Lindsay P, Bayley M, Hellings C, Hill M, Woodbury E, Phillips S. Canadian best practice recommendations for stroke care. CMAJ 2008 Dec 2;179(12 Suppl).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Canadian Best Practice Recommendations for Stroke Care include an ongoing plan to formally update the recommendations every 2 years to ensure that the best practice recommendations remain current and are coordinated with other similar initiatives nationally and internationally.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="HCPCS: Mental health services, not otherwise specified "/><FieldValue Value="ICD9CM: Cerebral artery occlusion, unspecified with cerebral infarction  (434.91); Dysphagia, unspecified  (787.20); Major depressive affective disorder, recurrent episode, unspecified  (296.30); Major depressive affective disorder, single episode, unspecified  (296.20); Mild cognitive impairment, so stated  (331.83); Screening for depression  (V79.0); Unspecified intracranial hemorrhage  (432.9); Unspecified nutritional deficiency  (269.9); Unspecified transient cerebral ischemia  (435.9); Vascular dementia, uncomplicated  (290.40)"/><FieldValue Value="MSH: Antidepressive Agents ; Brain Ischemia ; Cholinesterase Inhibitors ; Cognition Disorders ; Counseling ; Deglutition ; Deglutition Disorders ; Dementia ; Depression ; Depressive Disorder ; Diagnostic Techniques, Neurological ; Drug Therapy ; Fluoroscopy ; Galantamine ; Indans ; Intracranial Hemorrhages ; Ischemic Attack, Transient ; Malnutrition ; Mental Health Services ; Neuropsychological Tests ; Patient Care Team ; Patient-Centered Care ; Piperidines ; Pneumonia, Aspiration ; Preventive Health Services ; Psychotherapy ; Referral and Consultation ; Rehabilitation ; Risk Assessment ; Serotonin Uptake Inhibitors ; Stroke ; Telemedicine "/><FieldValue Value="MTH: Antidepressive Agents ; Aspiration Pneumonia ; Brain hemorrhage ; Brain Ischemia ; Cerebrovascular accident ; Cholinesterase Inhibitors ; Cognition Disorders ; Counseling ; Deglutition ; Deglutition Disorders ; Dementia ; Depression screen ; Depressive Disorder ; Encounter due to screening for depression ; Fall prevention ; Fall risk assessment ; Fluoroscopy ; Impaired cognition ; Ischemic stroke ; Malnutrition ; Malnutrition screen ; Mental Depression ; Pharmacotherapy ; Psychotherapy ; Rehabilitation therapy ; Risk Assessment ; Serotonin Uptake Inhibitors ; Telemedicine ; Transient Cerebral Ischemia ; Transient Ischemic Attack "/><FieldValue Value="PDQ: dysphagia ; malnutrition "/><FieldValue Value="SNOMEDCT_US: Anticholinesterase drug  (372765004); Anticholinesterase drug  (52761007); Antidepressant  (36236003); Antidepressant  (372720008); Aspiration pneumonia  (422588002); Attention training  (228550005); Cerebral artery occlusion  (20059004); Cerebrovascular accident  (230690007); Cognitive disorder  (443265004); Counseling  (129441002); Counseling  (409063005); Deglutition  (54731003); Dementia  (52448006); Depression screening  (171207006); Depressive disorder  (21061000119107); Depressive disorder  (35489007); Difficulty swallowing  (288939007); Difficulty swallowing  (40739000); Donepezil  (108497001); Donepezil  (386855006); Drug therapy  (416608005); Fall prevention  (386296001); Fall risk assessment  (414191008); Fluoroscopy  (312275004); Fluoroscopy  (44491008); Galantamine  (323377002); Galantamine  (395727007); Impaired cognition  (386806002); Intracranial hemorrhage  (1386000); Ischemic encephalopathy  (389100007); Ischemic stroke  (422504002); Malnutrition screening  (171184005); Mental health service  (708168004); Multi-infarct dementia, uncomplicated  (191463004); Multi-infarct dementia, uncomplicated  (70936005); Neuropsychological testing  (307808008); Psychotherapy  (75516001); Recurrent major depressive episodes  (268621008); Recurrent major depressive episodes  (66344007); Rehabilitation therapy  (52052004); Risk assessment  (225338004); Single major depressive episode  (268620009); Single major depressive episode  (36923009); Stroke prevention  (135875009); Stroke rehabilitation  (2517002); Swallowing status  (405035003); Transient cerebral ischemia  (266257000); Undernutrition  (248325000); Undernutrition  (47563007); Undernutrition  (65404009); Undernutrition  (70241007)"/><FieldValue Value="UMD: Fluoroscopic Units  (18-433)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Stroke and transient ischemic attack &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Complications of stroke&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Dysphagia &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Depression &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Vascular cognitive impairment and dementia &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Evaluation" /><FieldValue Value="Management" /><FieldValue Value="Prevention" /><FieldValue Value="Risk Assessment" /><FieldValue Value="Screening" /><FieldValue Value="Treatment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Critical Care" /><FieldValue Value="Family Practice" /><FieldValue Value="Geriatrics" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Neurology" /><FieldValue Value="Nursing" /><FieldValue Value="Pediatrics" /><FieldValue Value="Physical Medicine and Rehabilitation" /><FieldValue Value="Preventive Medicine" /><FieldValue Value="Psychiatry" /><FieldValue Value="Psychology" /><FieldValue Value="Speech-Language Pathology" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Dietitians" /><FieldValue Value="Emergency Medical Technicians/Paramedics" /><FieldValue Value="Health Care Providers" /><FieldValue Value="Hospitals" /><FieldValue Value="Nurses" /><FieldValue Value="Occupational Therapists" /><FieldValue Value="Pharmacists" /><FieldValue Value="Physical Therapists" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /><FieldValue Value="Psychologists/Non-physician Behavioral Health Clinicians" /><FieldValue Value="Social Workers" /><FieldValue Value="Speech-Language Pathologists" /><FieldValue Value="Utilization Management" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To provide a synthesis of best practices in stroke care across the continuum of care and serve as a framework for Canadian provinces and territories as they develop and implement stroke strategies&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;All patients with stroke&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Assessment/Screening&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Screening and clinical assessment swallowing ability &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of risk for malnutrition &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for depression &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for cognitive impairment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Additional cognitive and/or neuropsychological assessments as needed &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for risk of falls &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of circumstances related to falls &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Management&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Implementation and organization of a telestroke network &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management of patients with depression (antidepressant medications [selective serotonin reuptake inhibitors], psychological therapy, psychosocial support, counseling, monitoring of response) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management of vascular cognitive impairment (referral to specialist care utilizing a team approach, individualized rehabilitation, attention training, compensatory strategies, referral to mental health professional, pharmacotherapy [cholinesterase inhibitors, galantamine, donepezil]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Implementation of individualized fall prevention plan &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xA;    &lt;li&gt;Availability of telestroke network &lt;/li&gt;&#xA;    &lt;li&gt;Complications of dysphagia (pulmonary aspiration, pneumonia) &lt;/li&gt;&#xA;    &lt;li&gt;Accuracy of screening tests for dysphagia and depression &lt;/li&gt;&#xA;    &lt;li&gt;Malnutrition&lt;/li&gt;&#xA;    &lt;li&gt;Prevalence, incidence and associated factors for pre-stroke and post-stroke dementia &lt;/li&gt;&#xA;    &lt;li&gt;Incidence and circumstances of falls and the frequency of fall-related fractures &lt;/li&gt;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Secondary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Literature Search&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;MEDLINE, EMBASE and the Cochrane Library databases were rigorously searched. Also, the grey literature and websites of other best practice recommendation developers were searched for relevant material that may not have been published in an academic journal.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The time frame of each literature search ran from the time the best practice recommendation was last updated (2008) up until September, 2010. Unless invalid, the literature from the previously reviewed recommendations, completed in 2006 and 2008, was included. For new recommendations, the literature search time frame was from 1990 until September, 2010.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The following studies were included during the search: randomized controlled clinical trials (double-blinded or nonblinded); meta-analyses of randomized studies; nonrandomized controlled clinical trials and case series; population-based, consecutive series; consecutive cases (not population-based); or, non-consecutive cases. Included articles were published in English and were based on human studies.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All terms used were particular to stroke and the topic being searched. A total of 35 different topics were explored. Specific drug names, treatment names, and therapy names were used to create an inclusive database for each topic. This resulted in a total of 699 references included in the Canadian Stroke Best Practice Recommendations 2010 update.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A total of 699 studies were included.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Expert Consensus" /><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Summary of Definitions for Levels of Evidence*&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Rating Scheme for the Strength of the Evidence&quot; cellpadding=&quot;3&quot; width=&quot;50%&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Grade&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Criteria&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Strong recommendation. Evidence from randomized controlled trials or meta-analyses of randomized controlled trials. Desirable effects clearly outweigh undesirable effects, or vice versa. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Single randomized controlled trial or well-designed observational study with strong evidence; or well-designed cohort or case&amp;ndash;control analytic study; or multiple time series or dramatic results of uncontrolled experiment. Desirable effects closely balanced with undesirable effects. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;At least one well-designed, nonexperimental descriptive study (e.g., comparative studies, correlation studies, case studies) or expert committee reports, opinions and/or experience of respected authorities, including consensus from development and/or reviewer groups. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Based on Guyatt GH, Cook DJ, Jaeschke R, et al. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). [published erratum in Chest 2008;34:47]. Chest 2008;133(6 Suppl):123S-131S.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Evaluating the Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A Stroke Best Practices Recommendations Matrix was developed that mapped other existing stroke-related recommendations and their levels of evidence onto topic areas identified as relevant to optimal stroke care in Canada (i.e., blood pressure management, organization of care).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A list of topics was generated by identifying recommendations with the highest levels of evidence in each of the reference guidelines. Where similar or related recommendations on a particular topic appeared in more than two guidelines, it was added to the topic list. The final list of topics was then cross-referenced with the Stroke Canada Optimization of Rehabilitation through Evidence (SCORE) and the Canadian Stroke Quality of Care Study (CSQCS) studies.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Best Practices Recommendations Matrix was created through an iterative process of review and discussion among the members of the sub-group and the Best Practices and Standards Working Group (BPS-WG) as a whole.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Evaluation of Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Each recommendation included in this document was evaluated against several criteria: strength of the available research evidence to support the recommendation; degree to which the recommendation drives system change or processes of care delivery; overall validity and relevance as a core recommendation for stroke care along the continuum of care. The levels of evidence included in this document are determined through a structured ranking system which measures the strength of the results in a clinical trial or research study. The design of the study (such as a case report for an individual patient or a randomized double-blinded controlled clinical trial) and the endpoints measured (such as survival or quality of life) affect the strength of the evidence.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The various types of study designs, in descending order of strength, include:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Randomized controlled clinical trials (double-blinded or non-blinded) are considered the gold standard of study design. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Meta-analyses of randomized studies offer a quantitative synthesis of previously conducted studies. The strength of evidence from a meta-analysis is based on the quality of the conduct of individual studies. Meta-analyses of randomized studies are placed in the same category of strength of evidence as are randomized studies. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nonrandomized controlled clinical trials &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Case series: Population-based, consecutive series, consecutive cases (not population-based) or nonconsecutive cases. These clinical experiences are the weakest form of study design, but often they are the only available or practical information. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Several rating systems are used by guideline developers to evaluate the strength of the evidence for their recommendations. These systems vary in the nomenclature used (alphabetical versus numeric), but there is usually reasonable equivalence in the definitions across the levels of evidence. Each recommendation in this document provides the level of evidence for the recommendation (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field), as well as the reference for the Primary Guideline(s) that were adapted or contributed most to the wording of the recommendation.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus (Consensus Development Conference)" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Stroke Guideline Development Framework&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The conceptual framework used to guide the identification, selection, development and updating of the Canadian best practice recommendations was the Practice Guideline Evaluation and Adaptation Cycle of Graham and colleagues. This cycle involves a number of steps that are integral to the guideline development process:&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Establishing an interdisciplinary guideline development team &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Establishing a guideline appraisal process using a validated tool &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Systematic searching for existing practice guidelines &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Appraising the quality, currency and content of guideline recommendations &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Adopting or adapting guidelines for local use &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Obtaining external expert feedback on the proposed recommendations &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Selecting final recommendations &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Obtaining official endorsement &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Establishing an ongoing review and update process &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;The methodology for the first edition of the &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care (2006)&lt;/em&gt; was based on this framework, and it is applied, with some enhancements, to develop each update. The key activities undertaken in the guideline development process are highlighted below.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Leadership and Participants&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Canadian Stroke Strategy (CSS) Best Practices and Standards Working Group has overall responsibility for the development and update process. The 2010 update cycle was led by a subgroup of the Working Group and managed by the Director of Performance and Standards at the Canadian Stroke Network (CSN).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;An interprofessional group of experts in stroke care participated in topic-specific task groups convened to review, draft, and revise recommendation statements for their topic. Recognized experts within the topic area chaired each task group, and members included stroke neurologists, physiatrists, nurses, emergency physicians, paramedics, physical therapists, occupational therapists, dietitians, speech&amp;ndash;language pathologists, pharmacists, stroke survivors, education experts, and professionals from other disciplines as required. This interprofessional approach ensured that all relevant health disciplines for a particular topic area were represented in the development of the recommendations.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A national interprofessional consensus panel was convened to provide further input into the recommendations and a final review was conducted by an external group of stroke and methods experts before release.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Identification of Key Topic Areas and Core Reference Guidelines&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The process used to identify key topic areas and core reference guidelines is outlined below.&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;An ongoing structured literature review is conducted every two to three months to monitor emerging evidence and new or updated stroke-related guidelines. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Scans of the primary research literature focused on meta-analyses, systematic reviews, randomized trials, quasi-experimental studies, other related guidelines and reports, and Canadian consensus statements by healthcare professional groups &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The strength of the research evidence was graded using a standardized grading system (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field). In some areas, the levels of evidence for a given topic varied among selected guidelines or research papers depending on the nature of the research. The totality of the information for each topic provided a comprehensive understanding of the strength of the evidence, the state of the research, and gaps for future inquiry. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A detailed literature search for international stroke-related guidelines was also undertaken. The Appraisal of Guidelines Research and Evaluation (AGREE) tool was applied to determine the quality of the guidelines. This tool can be used to assess the process of guideline development based on six domains: identification of a clinical area to promote best practice, stakeholder involvement, rigour of development, clarity and presentation, applicability, and editorial independence. Based on the results of the appraisals, several guidelines met the Working Group criteria to be considered as 'reference guidelines' for the development process. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Once the high-quality guidelines were identified, a content review was conducted to identify a list of stroke topic areas that were supported by the highest levels of evidence. A secondary list of topic areas with lower levels of supporting evidence but considered being key system drivers (such as acute diagnostic imaging with computed tomography scans) was also compiled. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Potential topics that emerged from the research and guideline review were compiled into a &quot;Topic Matrix&quot; to allow easy comparison by topic and strength of evidence. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The topic areas and levels of supporting evidence were reviewed and debated by the Working Group. Using a consensus model, a final list of stroke topic areas that were considered most relevant to optimal stroke care in Canada was developed. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Topic areas were assigned to one of eight task groups to develop detailed recommendation statements. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;See Appendix 7 in the original guideline document for a list of guidelines and significant research trials that were considered during the 2010 update process.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Synthesis of Best Practice Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Expert task groups (see Appendix 2 in the original guideline document for a list of task group members) were convened for each segment of the continuum of stroke care, to select relevant recommendations arising from the evidence review and if necessary draft new recommendations based on emerging evidence. Task groups were instructed that recommendations could address structure and/or processes of care at either the system level or the patient level, and that they could be taken directly from other existing guidelines, adapted from one or more guidelines, or written by the task group. Appropriate references were to accompany all recommendation statements derived from evidence or existing guidelines.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For the 2010 update, each task group participated in a series of teleconferences between May 2009 and February 2010 to complete their research reviews and develop the recommendations. The&amp;nbsp;Director of Performance and Standards at the CSN participated in all teleconferences to ensure consistency, standardization, and rigour of development across task groups.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;See the original guideline document for more information on the recommendation development process.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="External Peer Review" /><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;National Expert Consensus Process&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Following completion of the task group work, the draft recommendations and supporting information were presented for discussion and decision-making to a broad group of stakeholders at a national expert consensus meeting held in Toronto, Ontario in April, 2010 (see Appendix 3 of the original guideline document for a list of consensus participants). Consensus participants included the Best Practices Working Group, the chairs of each task group, and invited opinion leaders, stroke survivors, and healthcare professionals external to the development process. The selection of consensus participants was based on ensuring representation from stroke-related health professional disciplines, all sectors of the healthcare continuum, all provinces in Canada, and rural and urban work environments.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Consensus participants received the draft recommendations, including proposed changes to existing recommendations as well as new recommendations, in advance of the consensus meeting. They were asked to review the information, provide feedback to the Working Group prior to the meeting, and indicate their degree of support for each recommendation. Votes were taken after each topic area discussion.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Definitions of the levels of evidence (A-C) are provided at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Note from the Canadian Stroke Network/Heart &amp;amp; Stroke Foundation of Canada (CSN/HSFC) and the National Guideline Clearinghouse (NGC)&lt;/strong&gt;: The &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt;, 2010 update, has been divided into individual summaries. In addition to the current summary, the following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34085&quot; title=&quot;Guideline #8610&quot;&gt;Public awareness of stroke&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34087&quot; title=&quot;Guideline #8611&quot;&gt;Prevention of stroke&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34088&quot; title=&quot;Guideline #8612&quot;&gt;Hyperacute stroke management&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34090&quot; title=&quot;Guideline #8613&quot;&gt;Acute stroke management&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34091&quot; title=&quot;Guideline #8614&quot;&gt;Stroke rehabilitation&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;a href=&quot;/content.aspx?id=34092&quot; title=&quot;Guideline #8615&quot;&gt;Managing stroke care transitions&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;What's New for 2010?&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The 2010 content update focuses on:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Access: Providing good stroke care, quickly &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Continuity: Helping people move smoothly through the stroke continuum, from symptom onset to diagnosis, treatment, management, and recovery &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;For 2010 the SCORE (Stroke Canada Optimization of Rehabilitation through Evidence) recommendations for upper and lower limb have been integrated within the Canadian Best Practice Recommendations for Stroke Care. Also new for 2010 is a section on transitions of care to help patients, families, and caregivers access the right type of care in the right settings at the right time. To facilitate uptake of the best practice recommendations by front-line clinicians, the best practice recommendations also include a new section on information about implementation resources.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Other significant changes for 2010:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Atrial fibrillation and carotid endarterectomy recommendations were revised to address the findings of two recently published clinical trials (RE-LY and CREST), which have important implications for stroke prevention. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Intracranial hemorrhage and subarachnoid hemorrhage recommendations were revised and expanded to address immediate assessment and management of these patients. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;New recommendations on fall prevention to address an important patient safety issue &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Cross-Continuum Topics in Stroke Management&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The recommendations in this guideline apply across the continuum of stroke care, from symptom onset through short-term recovery. Telestroke is a new recommendation for 2010 and emphasizes the need to use alternative methods to increase access to stroke expertise for all stroke patients. In addition, screening for and management of vascular cognitive impairment and post-stroke depression should be revisited beyond the post-acute recovery phase and return to the community.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Best Practice Recommendation: Telestroke&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Telestroke networks should be implemented wherever acute care facilities do not have on-site stroke care expertise to provide 24/7 acute stroke assessment and treatment with tissue plasminogen activator in accordance with current treatment guidelines [&lt;strong&gt;Evidence Level C&lt;/strong&gt;] (Schwamm et al., 2009).&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Organization of Telestroke Delivery for Hyperacute Stroke Management&lt;/strong&gt;&#xD;&#xA;    &lt;p&gt;Standardized protocols should be established to ensure a coordinated and efficient approach to telestroke service delivery in the hyperacute phase of stroke to facilitate delivery of thrombolytic therapy in referring sites [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] (Schwamm et al., 2009; Heart and Stroke Foundation: BC Stroke Strategy, 2010).&lt;/p&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Telestroke consultation should be continuously available at the referring and consulting sites [&lt;strong&gt;Evidence Level C&lt;/strong&gt;] (see the original guideline document for the definitions of terms used in this section). &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Clearly defined criteria and protocols should be available for referring sites to determine when and how to initiate a telestroke referral [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Two-way audiovisual communication should be in place to enable remote clinical assessment of the patient [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The consultant should be a physician with specialized training in stroke management, and must have access to diagnostic-quality computed tomography (CT) images during the telestroke consultation (see Technical Notes in the original guideline document) [&lt;strong&gt;Evidence Level A&lt;/strong&gt;].&#xD;&#xA;        &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;            &lt;li&gt;Compared with traditional bedside evaluation and use of intravenous tissue plasminogen activator, the safety and efficacy of intravenous tissue plasminogen activator administration based solely on telephone consultation without CT interpretation via teleradiology is not well established [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;/ol&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot; start=&quot;5&quot;&gt;&#xD;&#xA;        &lt;li&gt;All laboratory and diagnostic results required by the consultant should be made available during the telestroke consultation [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The most responsible physician remains the attending physician at the referring site. Decision-making is a consensus process that is achieved in consultation with the attending medical staff at the referring site, the patient and family, and the consulting physician with stroke expertise [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;A consulting physician should remain available to provide ongoing guidance to the referring site as required [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Standardized documentation should be completed by both the referring site and the consulting site [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;At the completion of the consultation, the consulting physician should provide a consultation note to the referring site to be included in the patient medical record [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;2&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Organization of Telestroke Delivery for Ongoing Stroke Management&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Two-way audiovisual communication should be in place to enable post&amp;ndash;acute stroke prevention and rehabilitation services in communities where these services do not exist [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Clearly defined criteria and protocols or algorithms should be available for referring sites to determine when and how to access these services for stroke patients [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The consulting healthcare provider should provide documentation to the referring site to be included in the patient medical record [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;3&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Staff Training and Ongoing Education&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Service providers should be trained in using the telestroke system and understand their roles and responsibilities. Telestroke training and education should be ongoing to ensure competency [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Referring physicians should know the inclusion and exclusion criteria for thrombolytic therapy and they should be familiar with the National Institutes of Health Stroke Scale (NIHSS) so that they are able to assist the telestroke consultant with the video neurological examination. Ideally referring physicians should be certified in the NIHSS [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Consulting physicians should have expertise and experience in managing stroke patients [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Rationale&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Telestroke enables improved communication and better networking to increase access to and distribution of optimal stroke care. It assists in closing the urban/rural and tertiary/primary care gap. In many communities there are no neurologists or physicians with expertise in stroke care, and the short therapeutic time window for initiating thrombolytic therapy for acute ischemic stroke patients does not allow them to be transported long distances to regional stroke centres. Telestroke brings an experienced stroke consultant into the local emergency department &quot;electronically&quot;. Patients assessed by a telestroke system who are not deemed to be candidates for tissue plasminogen activator still benefit from the stroke specialist's assessment and recommendations for optimal investigations and treatment.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Telestroke networks can also be used to facilitate early triage and management of transient ischemic attack and minor stroke, and may play a valuable role in post-acute rehabilitation and support.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Best Practice Recommendation: Dysphagia Assessment&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Patients with stroke should have their swallowing ability screened using a simple, valid, reliable bedside testing protocol as part of their initial assessment, and before initiating oral intake of medications, fluids or food [&lt;strong&gt;Evidence Level B&lt;/strong&gt;].&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patients who are not alert within the first 24 hours should be monitored closely and dysphagia screening performed when clinically appropriate [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients with stroke presenting with features indicating dysphagia or pulmonary aspiration should receive a full clinical assessment of their swallowing ability by a speech&amp;ndash;language pathologist or appropriately trained specialist(s) who should advise on safety of swallowing ability and consistency of diet and fluids [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients who are at risk of malnutrition, including those with dysphagia, should be referred to a dietitian for assessment and ongoing management. Assessment of nutritional status should include the use of validated nutrition assessment tools or measures [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. See the NGC summary of the CSN/HSFC guideline &lt;a href=&quot;/content.aspx?id=34090&quot; title=&quot;Guideline #8613&quot;&gt;Acute Stroke Management&lt;/a&gt; for additional information. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Rationale&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Dysphagia, or difficulty swallowing, occurs in approximately 55% of people with new-onset strokes. Only about 50% of those affected recover their normal swallowing ability by six months after onset. Dysphagia may lead to poor nutrition and dehydration and can result in aspiration leading to pneumonia. Use of a screening tool followed by a detailed swallowing analysis by a trained health care professional can enhance early recognition of dysphagia.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Best Practice Recommendation: Identification and Management of Post-Stroke Depression&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All patients with stroke should be considered to be at high risk for depression. During the first assessment, the clinical team should determine whether the patient has a history of depression or risk factors for depression [&lt;strong&gt;Evidence Level B&lt;/strong&gt;].&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;    &lt;li&gt;All patients with stroke should be screened for depression using a validated tool [&lt;strong&gt;Evidence Level A&lt;/strong&gt;] (SCORE). Screening should take place at all transition points and whenever clinical presentation indicates. Transition points may include:&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Upon admission to acute care, particularly if any evidence of depression or mood change is noted &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Before discharge to the community from acute care or during early rehabilitation if transferred to inpatient rehabilitation setting &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Periodically during inpatient rehabilitation &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Periodically following discharge to the community &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: lower-roman;&quot; start=&quot;2&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patients identified as being at risk for depression during screening should be referred to a healthcare professional with expertise in diagnosis and management of depression in stroke patients [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. These patients should be referred to a psychiatrist or psychologist where available. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients with mild depressive symptoms should be managed by &quot;watchful waiting,&quot; with treatment being started only if the depression is persistent [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients diagnosed with a depressive disorder should be given a trial of antidepressant medication, if no contraindication exists. No recommendation is made for the use of one class of antidepressants over another; however, side effect profiles suggest that selective serotonin reuptake inhibitors may be favoured in this patient population [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;In adult patients with severe, persistent or troublesome tearfulness, selective serotonin reuptake inhibitors are recommended [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Treatment should be monitored and should continue for a minimum of six months if a good response is achieved [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Routine use of prophylactic antidepressants is not recommended in post-stroke patients [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients should be given information and advice about the impact of stroke, and the opportunity to talk about the impact on their lives [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients with marked anxiety should be offered psychological therapy [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients and their caregivers should have their psychosocial and support needs reviewed on a regular basis as part of long-term stroke management [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Rationale&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Post-stroke depression may affect as least one in every four individuals who have had a significant stroke event. The stroke patient is at greatest risk in the first six months after a stroke. Depression may affect a patient's ability to participate in post-stroke therapy and is associated with slower progress in rehabilitation and increased length of stay. Clinicians need to be watchful and recognize depression before it interferes significantly with therapy and the patient's well being. Standardized screening assessments for depression can indicate that depression exists and also can be used to monitor progress. However, there is no single, universally accepted tool for the assessment of post-stroke depression. An alternative to verbal scales to assess mood should be sought when assessing someone who is aphasic.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Anxiety should be assessed and treated, especially when found in conjunction with depressive symptoms. Antidepressant medications and counseling appear to be helpful in treating this condition. Aphasic patients provide a unique challenge for assessment and treatment.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Best Practice Recommendation: Vascular Cognitive Impairment and Dementia&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All patients with vascular risk factors and those with clinically evident stroke or transient ischemic attack should be considered at high risk for vascular cognitive impairment.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Patients considered at high risk for cognitive and perceptual impairment are those with vascular risk factors such as hypertension, age &amp;gt;65, hyperlipidemia, diabetes, clinical stroke, neuroimaging findings of covert stroke or white matter disease, hypertension-associated damage to other target organs, and/or those patients with cognitive or functional changes that are clinically evident or reported during history-taking.&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Assessment&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;All high-risk patients should be screened for cognitive impairment using a validated screening tool [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Screening to investigate a person's cognitive status should address arousal, alertness, attention, orientation, memory, language, agnosia, visuospatial/perceptual function, praxis and executive functions such as insight, judgment, social cognition, problem-solving, abstract reasoning, initiation, planning and organization [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The Montreal Cognitive Assessment is considered more sensitive to cognitive impairment than the Mini Mental Status Exam in patients with vascular cognitive impairment. Its use is recommended when vascular cognitive impairment is suspected [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] (Chertkow, 2007). Additional validation is needed for the Montreal Cognitive Assessment as well as other potential screening instruments such as the 5-minute protocol from the Vascular Cognitive Impairment Harmonization recommendations. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Post-stroke patients should also be screened for depression, since depression has been found to contribute to cognitive impairment in stroke patients. A validated screening tool for depression should be used [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] (Chertkow, 2007). Refer to recommendation below for additional information &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Post-stroke patients who have cognitive impairment detected on a screening test should receive additional cognitive and/or neuropsychologic assessments as appropriate to further guide management [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] (Chertkow, 2007). &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;2&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Timing&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;All patients considered at high risk for cognitive impairment should be assessed periodically as indicated by severity of clinical presentation, history and/or imaging abnormalities to identify cognitive, perceptual deficits, depression, delirium and/or changes in function [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Those who have had a transient ischemic attack or stroke should be assessed using a validated screening tool and, where indicated, undergo a more in-depth assessment of cognitive and perceptual status at various transition points throughout the continuum of stroke care [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. Transition points may include:&#xD;&#xA;        &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;            &lt;li&gt;During presentation to emergency when cognitive, perceptual or functional concerns are noted &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Upon admission to acute care, particularly if any evidence of delirium is noted &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Upon discharge home from acute care or during early rehabilitation if transferred to inpatient rehabilitation setting &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Periodically during in-patient rehabilitation stage according to client progress and to assist with discharge planning &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Periodically following discharge to the community by the most appropriate community healthcare provider according to client's needs, progress and current goals. &lt;/li&gt;&#xD;&#xA;        &lt;/ol&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;3&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Management&lt;/strong&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;        &lt;li&gt;All vascular risk factors should be managed aggressively to achieve optimal control [&lt;strong&gt;Evidence Level A&lt;/strong&gt;]. See the NGC summary of the CSN/HSFC guideline Prevention of Stroke for additional information. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Patients who demonstrate cognitive impairments in the screening process should be referred to a healthcare professional with specific expertise in this area for additional cognitive, perceptual and/or functional assessments [&lt;strong&gt;Evidence Level B&lt;/strong&gt;].&#xD;&#xA;        &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;            &lt;li&gt;Additional assessments should be undertaken to determine the severity of impairment and impact of deficits on function and safety in activities of daily living and instrumental activities of daily living, and to implement appropriate remedial, compensatory and/or adaptive intervention strategies [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;A team approach is recommended, and healthcare professionals may include an occupational therapist, neuropsychologist, psychiatrist, neurologist, geriatrician, speech-language pathologist or social worker [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;/ol&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot; start=&quot;3&quot;&gt;&#xD;&#xA;        &lt;li&gt;An individualized, patient-centred approach should be considered to facilitate resumption of desired activities such as return to work, leisure, driving, volunteer participation, financial management, home management and other instrumental activities of daily living [&lt;strong&gt;Evidence Level C&lt;/strong&gt;] (Chertkow, 2007). &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Intervention strategies including rehabilitation should be tailored according to the cognitive impairments and functional limitations as well as remaining cognitive abilities, as identified through in-depth assessment and developed in relation to patients' and caregivers' needs and goals [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Strategy training provides individuals who have limitations in activities of daily living with compensatory strategies to promote independence and should be offered to patients with cognitive challenges [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. The evidence for the effectiveness of specific interventions for cognitive impairment in stroke is limited and requires more research.&#xD;&#xA;        &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;            &lt;li&gt;Attention training may have a positive effect on specific, targeted outcomes and should be implemented with appropriate patients [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Compensatory strategies can be used to improve memory outcomes [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;/ol&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-roman;&quot; start=&quot;6&quot;&gt;&#xD;&#xA;        &lt;li&gt;Patients with evidence of depression or anxiety on screening should be referred and managed by an appropriate health professional [Evidence Level C]. See the NGC summary of the CSN/HSFC guideline &lt;a href=&quot;/content.aspx?id=34092&quot; title=&quot;Guideline #8615&quot;&gt;Managing Stroke Care Transitions&lt;/a&gt; for additional information. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;&lt;strong&gt;Pharmacotherapy&lt;/strong&gt;&#xD;&#xA;        &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;            &lt;li&gt;Patients with evidence of vascular cognitive impairment should be referred to a physician with expertise in vascular cognitive impairment for further assessment and recommendations regarding pharmacotherapy [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Cholinesterase inhibitors should be considered for management of vascular cognitive impairment diagnosed using the National Institute of Neurological Disorders and Stroke (NINDS) &amp;ndash; Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN) diagnostic criteria [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] (Chertkow, 2007). &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;There is fair evidence of small magnitude benefits for galantamine on cognition function and behaviour in mixed Alzheimer and cerebrovascular disease. Galantamine can be considered a treatment option for mixed Alzheimer and cerebrovascular disease [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;There is fair evidence of small magnitude benefits for donepezil in cognitive and global outcomes, with less robust benefits on functional measures. Donepezil can be considered a treatment option for vascular dementia [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;/ol&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Rationale&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Vascular cognitive impairment affects up to 60 percent of stroke survivors and is associated with decreased function in activities of daily living and instrumental activities of daily living. Patients may require long-term, ongoing intervention and/or rehabilitation. It has been suggested that cognitive abilities such as abstract thinking, judgment, short-term memory, comprehension and orientation are important in predicting functional status at discharge. In addition, cognitive impairment can be chronic and progressive after stroke; post-stroke dementia is estimated to occur in 26 percent of stroke patients by three months (95% CI 3% in age-matched controls) and adversely affects recovery. Cognitive impairment increases long-term dependence and is associated with higher mortality (61 percent versus 25 percent).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Cognitive impairment due to covert vascular pathology is also increasing. Covert strokes, usually lacunes, are common (23 percent of community elderly) and are associated with cognitive decline, dementia, and stroke. Evidence is emerging that demonstrates that for every clinically evident stroke, there are six to nine so-called &quot;covert&quot; strokes. Signs of covert stroke are often manifested as cognitive impairment signs and symptoms. Intracerebral small-vessel disease is a significant issue that is on the rise with the aging of the population, leading to an increase in the need for long-term care support services.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In most population studies, vascular dementia is the second most common cause of dementia, after Alzheimer disease. The combination of Alzheimer disease and vascular disease results in the commonest substrate of dementia in the elderly. A single macroscopic hemispheral infarct is sufficient to cause dementia in people with intermediate Alzheimer pathology.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Best Practice Recommendation: Falls Prevention and Management&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All patients post stroke should be screened for risk of falls by an experienced clinician at admission, whenever there is a change in patient health status, and at transition points [&lt;strong&gt;Evidence Level C&lt;/strong&gt;].&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: lower-roman;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Screening for risk of falls should include identification of medical, functional, cognitive, and environmental factors associated with potential falls and fall injuries [&lt;strong&gt;Evidence Level B&lt;/strong&gt;] (Registered Nurses Association of Ontario, 2005). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Those found to be at risk for falls should undergo a comprehensive interprofessional falls assessment that includes medical and functional history, and examination of mobility, vision, perception, cognition, and cardiovascular status [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Based on the risk assessment findings, an individualized falls prevention plan should be implemented for each patient [&lt;strong&gt;Evidence Level C&lt;/strong&gt;).&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-alpha;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Patients should be educated regarding their risk for falls and precautions to take to reduce their risk [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Families and caregivers should be provided with education and skills training for transferring and mobilizing the stroke patient [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Topics addressed in patient, family, and caregiver education should include footwear, direction of transfer, gait aids, transfer belt use, seatbelt use, arm support devices, foot rests, and brakes [&lt;strong&gt;Evidence Level B&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: lower-roman;&quot; start=&quot;4&quot;&gt;&#xD;&#xA;    &lt;li&gt;All patients who fall post-stroke should have an assessment of the circumstances surrounding the fall to identify precipitating factors, and the falls prevention plan should be modified to reduce the risk of further falls [&lt;strong&gt;Evidence Level C&lt;/strong&gt;]. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Rationale&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Patients with stroke are at higher risk for falls than many other hospitalized patients. The reported incidence rate ranges from 14 to 65. Falls occur often within the first week following stroke during the acute phase, and then again as patient mobility increases. The interprofessional care team must be cognizant of the risk for falls and ensure appropriate assessments and interventions take place.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Summary of Definitions for Levels of Evidence*&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Rating Scheme for the Strength of the Evidence&quot; cellpadding=&quot;3&quot; width=&quot;50%&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Grade&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Criteria&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Strong recommendation. Evidence from randomized controlled trials or meta-analyses of randomized controlled trials. Desirable effects clearly outweigh undesirable effects, or vice versa. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Single randomized controlled trial or well-designed observational study with strong evidence; or well-designed cohort or case&amp;ndash;control analytic study; or multiple time series or dramatic results of uncontrolled experiment. Desirable effects closely balanced with undesirable effects. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;At least one well-designed, nonexperimental descriptive study (e.g., comparative studies, correlation studies, case studies) or expert committee reports, opinions and/or experience of respected authorities, including consensus from development and/or reviewer groups. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Based on Guyatt GH, Cook DJ, Jaeschke R, et al. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). [published erratum in Chest 2008;34:47]. Chest 2008;133(6 Suppl):123S-131S.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="98" OrdBy="605" ID="425" Name="References Supporting the Recommendations" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;BC Stroke Strategy. Emergency &amp; acute care: telemedicine. Available: http://www.bcstrokestrategy.ca/emergencyAcuteCare/telemedicine.html. [internet]. Vancouver (BC): Heart and Stroke Foundation; [accessed 2010 Sep 01]. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Chertkow H. Introduction: the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, 2006. Alzheimers Dement. 2007 Oct;3(4):262-5. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19595947&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Registered Nurses Association of Ontario. Nursing best practice guideline. Stroke assessment across the continuum of care. Toronto (ON): The Association; 2005. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Schwamm LH, Audebert HJ, Amarenco P, Chumbler NR, Frankel MR, George MG, Gorelick PB, Horton KB, Kaste M, Lackland DT, Levine SR, Meyer BC, Meyers PM, Patterson V, Stranne SK, White CJ, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Interdisciplinary Council on Peripheral Vascular Disease, Council on Cardiovascular Radiology and Intervention. Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke. 2009 Jul;40(7):2635-60. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19423851&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of evidence is specifically stated for each recommendation (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This document is the result of an extensive review of international stroke research and published evidence-based best practice recommendations or guidelines related to stroke.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Telestroke enables improved communication and better networking to increase access to and distribution of optimal stroke care. It assists in closing the urban/rural and tertiary/primary care gap. Telestroke networks can also be used to facilitate early triage and management of transient ischemic attack and minor stroke, and may play a valuable role in post-acute rehabilitation and support. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Appropriate screening can enhance early recognition of dysphagia. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Antidepressant medications and counseling appear to be helpful in treating depression. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Appropriate assessments and interventions can protect stroke patients from falls. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Side effects of medications&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;The Canadian Stroke Strategy (CSS) recognizes that human, financial, and system resource limitations may make it difficult to implement all recommendations in this document. However, the recommendations and performance measures are presented as &quot;gold standard&quot; benchmarks toward which all organizations and systems should strive. Additionally, these recommendations can be valuable tools and information sources for anyone advocating for improved stroke care services. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The recommendations in this document are better seen as guidelines rather than rigid rules. They are not meant to supplant clinical judgment and consideration of unique patient circumstances. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Every attempt has been made to keep these recommendations up to date; however, given the rapid evolution of stroke research, late-breaking evidence may not be reflected. For this update, the literature review completion date was September 30, 2010. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It was not feasible to present the expert panel with all available evidence, and therefore the primary evidence was initially screened and evaluated by the task groups. Wherever possible, late-breaking evidence was reviewed by the task group leaders to identify areas where the current recommendations might be significantly altered. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Networking and Distribution&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Canadian Stroke Strategy (CSS) makes the &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt; available openly and at no cost, in English and French. Publication and dissemination strategies have changed in response to user needs and feedback. In 2006, printed documents and CDs were provided to all contacts in the CSS database, to others on request, and to interested groups throughout Canada and internationally. The 2008 Update was published through the &lt;em&gt;Canadian Medical Association Journal&lt;/em&gt; (CMAJ) as a supplement to subscribers and posted on the CMAJ website with links to the document on the CSS website; the CSS provided a limited number of printed copies upon request. The 2010 Update is available on the Canadian Stroke Network (CSN) Best Practices web site, at &lt;a href=&quot;http://www.strokebestpractices.ca/&quot; title=&quot;CSN Web site&quot;&gt;www.strokebestpractices.ca&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Also on the website, patients and the general public can find &lt;em&gt;A Patient's Guide to the Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt;. The CSS created the patient's guide in recognition of the fact that the best practice recommendations are lengthy and written primarily for a healthcare audience.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The CSS encourages provincial or territorial and regional stroke strategies to adopt the &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt; in their entirety. While the process and speed of implementation will vary depending on circumstances, the vision of offering integrated, high quality, and efficient stroke services to all Canadians should be shared and supported across the country.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The CSS disseminates the &lt;em&gt;Canadian Best Practice Recommendations for Stroke Care&lt;/em&gt; by:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Posting the recommendations on the&amp;nbsp;Canadian Stroke Network Best Practices website and other central guideline repository websites such as the World Stroke Organization website, the National Guideline Clearinghouse, the Internet Stroke Centre, and the Canadian Medical Association website &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Writing feature articles for publications such as the &lt;em&gt;Canadian Medical Association Journal&lt;/em&gt; and the Canadian Stroke Network &lt;em&gt;Brainwaves&lt;/em&gt; newsletter &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Alerting all contacts in the CSS database of Updates and how to access them &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Encouraging others to set up electronic links to the recommendations (e.g., Canadian Stroke Network, Heart and Stroke Foundation of Canada, provincial stroke strategies) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Sharing details with all the CSS working groups to ensure alignment and collaboration in dissemination &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Engaging provincial stroke champions through presentations and discussion &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Consulting other national guideline groups in related fields (e.g., hypertension, dyslipidemia, diabetes) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Presenting at national, provincial, and regional meetings of healthcare professionals across healthcare disciplines and across the continuum of stroke care &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Making presentations to front-line healthcare professionals at the local level and using local consensus processes to review and provide structured assessment of the enablers and barriers to guideline implementation, as well as innovative implementation strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;E-mailing key stakeholders and front-line healthcare professionals working with persons with stroke and their families throughout the continuum of stroke care &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Highlighting specific recommendations in stroke-related newsletters such as the National Stroke Nursing Council's newsletter &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Disseminating the recommendations at international stroke meetings through the World Stroke Organization, the Guidelines International Network, and international partners and collaborators &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;The CSS encourages provincial or territorial and regional stroke strategy leaders to use these or other applicable approaches to further disseminate the recommendations and supporting tools to healthcare professionals, health system planners, decision-makers, and funders.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Tools to Support Implementation of the Best Practice Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The national professional development and training platform of the CSS focuses on developing and implementing an integrated professional development and training plan for stroke professionals who care for patients, families, and caregivers. Professional development and training activities are carried out by a sub-group of the Best Practices and Standards Working Group, using a three-pronged approach that encompasses pre-professional education, professional development, and systems change.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Several point-of-care tools have been developed and are available through the websites of the CSN at &lt;a href=&quot;http://www.strokebestpractices.ca/&quot; title=&quot;CSN Web site&quot;&gt;www.strokebestpractices.ca&lt;/a&gt; and the Heart and Stroke Foundation of Canada at &lt;a href=&quot;http://www.heartandstroke.com/&quot; title=&quot;Heart and Stroke Foundation of Canada Web site&quot;&gt;www.heartandstroke.com&lt;/a&gt;. These tools address pre-hospital care, acute stroke care, stroke unit care, prevention, and long-term care (refer to Appendix 8 of the original guideline document for a list of professional development resources). The target audiences for each tool vary, but generally these tools are relevant to all interprofessional team members in a given setting.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;See the original guideline document for System Implication Categories and Performance Measures Development.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Audit Criteria/Indicators" /><FieldValue Value="Foreign Language Translations" /><FieldValue Value="Patient Resources" /><FieldValue Value="Resources" /><FieldValue Value="Staff Training/Competency Material" /><FieldValue Value="Tool Kits" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /><FieldValue Value="Timeliness " /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Cross-continuum topics in stroke management. In: Lindsay MP, Gubitz G, Bayley M, Hill MD, Davies-Schinkel C, Singh S, Phillips S, Canadian Stroke Strategy Best Practices and Standards Writing Group. Canadian best practice recommendations for stroke care. Ottawa (ON): Canadian Stroke Network; 2010 Dec 8. p. 151-70.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2006 (revised 2010 Dec 8)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Canadian Stroke Network - Disease Specific Society" /><FieldValue Value="Heart and Stroke Foundation of Canada - Disease Specific Society" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The development of these Canadian stroke care guidelines is funded in its entirety by the Canadian Stroke Strategy, a joint initiative of the Canadian Stroke Network and the Heart and Stroke Foundation of Canada. The Canadian Stroke Strategy is funded primarily by the Canadian Stroke Network, which is in turn funded by the Networks of Centres of Excellence program.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;No funds for the development of these guidelines come from commercial interests, including pharmaceutical companies.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Canadian Stroke Strategy Best Practices and Standards Working Group&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Working Group Members&lt;/em&gt;: Stephen Phillips (&lt;em&gt;Co-Chair&lt;/em&gt;), Director, Acute Stroke Program, Queen Elizabeth II Health Sciences Centre, Nova Scotia; Mark Bayley (&lt;em&gt;Co-Chair&lt;/em&gt;), Physiatrist and Medical Director, Neuro Rehabilitation Program, Toronto Rehabilitation Institute, Ontario; Gord Gubitz, Lead, 2010 Best Practices Update; Neurologist, Acute Stroke Unit and Outpatient Neurovascular Clinic, Queen Elizabeth II Health Sciences Centre, Nova Scotia; Laurie Cameron, Program Coordinator &amp;amp; Executive Assistant, Canadian Stroke Strategy; Corrine Davies-Schinkel, Project Coordinator, Canadian Stroke Network; Michelle Edwards, Occupational Therapist, Foothills Medical Centre, Alberta; Ian Graham, Vice-President, Knowledge Translation, Canadian Institutes of Health Research; Mary Elizabeth Harriman, Associate Executive Director, Heart and Stroke Foundation of Canada; Anthony Herd, CAEP Representative, Emergency Physician, Winnipeg Regional Health Authority, Manitoba; Linda Kelloway, Best Practices Lead, Ontario Stroke Network, Ontario; Katie Lafferty, Executive Director, Canadian Stroke Network; Louise-H&amp;eacute;l&amp;egrave;ne LeBrun, Directeur du Centre des maladies vasculairesc&amp;eacute;r&amp;eacute;brales du CHUM, Centre Hospitalier de l'Universit&amp;eacute; de Montr&amp;eacute;al (CHUM), Quebec; Patrice Lindsay, Staff Lead, Director of Performance and Standards, Canadian Stroke Network; Samantha Singh, Project Coordinator, Canadian Stroke Network; Elizabeth Woodbury, Executive Director, Canadian Stroke Strategy&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Participants in the development and review process are required to sign confidentiality agreements and to declare all potential conflicts of interest in writing. Only seven&amp;nbsp;out of 143 participants declared a minor conflict such as receipt of honoraria to speak about stroke in other venues. None of these conflicts were deemed to prevent unbiased participation in the process. The recommendations were approved following a rigorous development process and through a consensus of independent experts and stakeholders, thereby minimizing the potential influence of any one participant. See Appendices 1, 2, 3, and 4 in the original guideline document for complete statements of competing interests.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="159" OrdBy="1255" ID="453" Name="Guideline Endorser(s)" Type="orglist"><FieldValue Value="World Stroke Organization - International Agency" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Lindsay P, Bayley M, Hellings C, Hill M, Woodbury E, Phillips S. Canadian best practice recommendations for stroke care. CMAJ 2008 Dec 2;179(12 Suppl).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Canadian Best Practice Recommendations for Stroke Care include an ongoing plan to formally update the recommendations every 2 years to ensure that the best practice recommendations remain current and are coordinated with other similar initiatives nationally and internationally.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) in &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/04/2010BPR_ENG.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/04/2010BPR_FRENCH.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Canadian Best Practice Recommendations for Stroke Care: 2008 toolkit. Available in English and French from the &lt;a href=&quot;http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.5398033/k.2C15/Canadian_Best_Practices_Workshop.htm&quot; title=&quot;Heart and Stroke Foundation of Ontario Web site&quot;&gt;Heart &amp;amp; Stroke Foundation of Ontario Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Secondary prevention best practice workshop tool kit: preventing strokes one at a time. Available from the &lt;a href=&quot;http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.5882219/k.48F5/Secondary_Prevention_Tool_Kit.htm&quot; title=&quot;Heart and Stroke Foundation of Ontario Web site&quot;&gt;Heart &amp;amp; Stroke Foundation of Ontario Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Acute stroke management workshop. Available in English and French from the &lt;a href=&quot;http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.5346923/k.8D25/HCP__English.htm&quot; title=&quot;Heart and Stroke Foundation of Ontario Web site&quot;&gt;Heart &amp;amp; Stroke Foundation of Ontario Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Canadian Best Practice Recommendations for Stroke Care: educational workshop for emergency medical care of suspected acute care patients. Available in Portable Document Format (PDF) in &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS_EMS-Stroke-Wksp_FINAL.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS_EMS_fr.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Canadian Stroke Strategy performance measurement manual: a supplement to the Canadian best practice recommendations for stroke care. 2008 May. 48 p. Electronic copies: Available in PDF in &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS-Performance-Manual-2008_EN.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS-Performance-Manuel-2008_FR.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Canadian Stroke Strategy core performance indicator update 2010. 2010 Jun. 8 p. Electronic copies: Available in PDF in &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/12/Stroke_Core_ENG.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/12/Stroke_Core_FRE.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A guide to the implementation of stroke unit care. A resource for implementation of Canadian Best Practice Recommendations for Stroke Care. 2009 Dec. 24 p. Available in PDF in &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS-Stroke-Unit-Resource_EN-Final2-for-print.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/CSS-Stroke-Unit-Resource_FR3-Final-for-print.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Additional resources are available in &lt;a href=&quot;http://www.strokebestpractices.ca/index.php/resources/&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://www.strokebestpractices.ca/index.php/resources/?lang=fr&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Best Practices Web site.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;A patient's guide to Canadian best practice recommendations for stroke care. 2011. 8 p. Electronic copies: Available in Portable Document Format (PDF) in &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/11/CSN_PatientsGuide2011_English_WEB11.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/11/CSN_PatientsGuide2011_French_WEB21.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Best Practices Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Getting on with the rest of your life after stroke: a guide for patients and their families. 68 p. Electronic copies: Available in PDF in &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/09/GettingOn2-EN.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://strokebestpractices.ca/wp-content/uploads/2010/11/French-Getting-On.pdf&quot; title=&quot;Canadian Stroke Network Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Web site. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A family guide to pediatric stroke. 2011. 34 p. Electronic copies: Available in Portable Document Format (PDF) in &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/10/PEDSGuide-EN.pdf&quot; title=&quot;Canadian Stroke Network Best Practices Web site&quot;&gt;English&lt;/a&gt; and &lt;a href=&quot;http://www.strokebestpractices.ca/wp-content/uploads/2011/10/PEDSGuide-FR.pdf&quot; title=&quot;Canadian Stroke Network Best Practices Web site&quot;&gt;French&lt;/a&gt; from the Canadian Stroke Network Best Practices Web site. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Additionally, a variety of patient information resources, including a list of stroke warning signs, is available from the &lt;a href=&quot;http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483933/&quot; title=&quot;Heart and Stroke Foundation of Canada Web site&quot;&gt;Heart &amp;amp; Stroke Foundation of Canada Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on July 14, 2008. The information was verified by the guideline developer on August 27, 2008. This NGC summary was updated by ECRI Institute on December 3, 2009. This NGC summary was updated by ECRI Institute on December 1, 2011. The updated information was verified by the guideline developer on January 9, 2012.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
